Video

Ilana Cass on Potential Consequences of Preventive Surgery

Author(s):

Ilana Cass, M.D.
Conference|FORCE Conference

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.

Ilana Cass, M.D. of Cedars-Sinai Medical Center, discusses the potential side effects that may occur after a preventive surgery for ovarian cancer. Some of the effects are yet unknown and standards for screening need to be developed.

Related Videos
Image of man with grey hair.
Image of woman with black hair.
Image of woman with blonde hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short black hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of man with black hair.
Image of a woman with layered hair, wearing a bright blue cardigan.
Related Content
Image of multiple myeloma cells.
December 21st 2024

Darzalex Regimen May Improve MRD Responses in Multiple Myeloma

Kristie L. Kahl
Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a Darzalex treatment combination.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of red blood cells.
December 18th 2024

Imbruvica-Venetoclax Shows Promise in Managing CLL

Spencer Feldman
A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of Dr. Brandon Blue.
December 17th 2024

Black Patients With Myeloma Face Taste, Skin Side Effects from Talvey

Alex Biese
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®.
Illustration of cross hairs on cancer in the blood.
December 16th 2024

Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL

Chris Ryan
Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.